期刊文献+

肝硬化门静脉高压症的诊断 被引量:5

Diagnosis of cirrhotic portal hypertension
原文传递
导出
摘要 门静脉高压症是消化系统常见病,指门静脉血流压力增高。肝硬化引起的门静脉高压症患病率高,目前认为由门静脉阻力(R)增加和门静脉血流量(Q)增加所致,肝脏结构改变所致的机械梗阻与神经、体液及代谢因素一同发挥着重要作用。临床表现包括腹腔积液、脾大、侧支循环形成与开放。诊断时须符合以下条件:满足肝硬化及门静脉高压症的诊断,但除外其他病因。 Summary:Portal hypertension (PH) refers to a common digestive system disease with elevated blood flow pressure in the portal vein. The cirrhosis-induced PH has a high incidence rate, which is mainly believed to be caused by an increase in resistance (R) and an increase in blood flow quantity (Q). Mechanical obstruction in- duced by altered liver structure together with nerve, body fluids and metabolic factors also play an important role in PH development. The clinical manifestations include ascites, splenomegaly and formation and opening of collateral circulations. The diagnostic criteria for cirrhosis and PH should be met when determining on a diagnosis, along with other causes ruled out.
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2011年第7期559-560,共2页 Chinese Journal of Practical Internal Medicine
关键词 肝硬化 门静脉高压症 cirrhosis portal hypertension
  • 相关文献

同被引文献47

  • 1You-Gang Ma, Xiao-Song Li, Jun Zhao, Han Chen and Meng-Chao Wu Department of Second Biliary Surgery, Eastern Hepa-tobiliary Hospital, Shanghai 200438, China.Modified Sugiura procedure for the management of 160 cirrhotic patients with portal hypertension[J].Hepatobiliary & Pancreatic Diseases International,2004,3(3):399-401. 被引量:6
  • 2吕胜军,高舒华,田琦.彩色多普勒超声观测脾动脉栓塞术对门静脉高压症患者门静脉血流动力学[J].中国实验诊断学,2004,8(6):664-665. 被引量:11
  • 3杨轲勇,褚燕君.乙型肝炎肝硬化患者血小板减少机制的相关因素[J].中国实用医刊,2010,37(5):70-71. 被引量:5
  • 4George Kolios,Vassilis Valatas,Elias Kouroumalis.Role of Kupffer cells in the pathogenesis of liver disease[J].World Journal of Gastroenterology,2006,12(46):7413-7420. 被引量:75
  • 5PENG L, XIE DY, LIN BL, et al. Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short - term and long - term out- comes[J]. Hepatology, 2011, 54(3):820-828.
  • 6KHARAZlHA P, HELLSTROM PM, NOORINAYER B, et al. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I - II clinicaltrial[J]. Eur Gastroenterol Hepatol, 2009, 21 (10}: 199 -205.
  • 7LYRA AC, SOARES MB, DA SILVA LF, et al. Infusion of autol- ogous bone marrow mononuclear cells through hepatic artery results in a short -term improvement of liver function in pa- tients with chronic liver disease: a pilot randomized controlled study[ J ]. Eur Gastroenterol Hepatol, 2910, 22 ( 1 ) : 33 -42.
  • 8DALAKAS E, NEWSOME PN, BOYLE S, et al. Bone mar- row stem cells contribute to alcohol liver fibrosis in humans [J]. Stem Cells, 2010, 19(9}: 1417 -1425.
  • 9SAKAIDA L, TERAI S, YAMAMOTO N, et al. Transplanta- tion of bone marrow cells reduces CCL4 -induced liver fibro- sis in mice[J]. Hepatology, 2004, 40(6) : 1304 -1311.
  • 10FANG B, Shl M, LIAO L, et al. Systemic infusion of FLK1 (+) mesenchymal stem cells ameliorate carbon tetrachlo- ride - induced liver fibrosis in mice [ J ]. Transplantation, 2004, 78(1 ) .. 83 -88.

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部